Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Nina N Sanford"'
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 7, Iss 3, Pp 150-158 (2024)
Introduction: Disparities in incidence and outcome of rectal cancer are multifactorial in etiology but may be due, in part, to differences in gut microbiome composition. We used serial robust statistical approaches to assess baseline gut microbiome c
Externí odkaz:
https://doaj.org/article/acbcefdb049a449e8bad6ad51dac3d27
Autor:
Brooke Rhead, David M. Hein, Yannick Pouliot, Justin Guinney, Francisco M. De La Vega, Nina N. Sanford
Publikováno v:
Genome Medicine, Vol 16, Iss 1, Pp 1-17 (2024)
Abstract Background There are known disparities in incidence and outcomes of colorectal cancer (CRC) by race and ethnicity. Some of these disparities may be mediated by molecular changes in tumors that occur at different rates across populations. Gen
Externí odkaz:
https://doaj.org/article/3cfcd8c860064e2684c9d19ea02cf116
Autor:
Stephen ShingFan Yip, Thibaud P Coroller, Nina N Sanford, Harvey eMamon, Hugo J.W.L. Aerts, Ross I. Berbeco
Publikováno v:
Frontiers in Oncology, Vol 6 (2016)
Purpose: Although change in SUV measures and PET-based textural features during treatment have shown promise in tumor response prediction, it is unclear which quantitative measure is the most predictive. We compared the relationship between PET-based
Externí odkaz:
https://doaj.org/article/5f40df7a8c0a426f975af22a38a373ef
Autor:
Sara Mheid, Stefan Allen, Sylvia S. W. Ng, William A. Hall, Nina N. Sanford, Todd A. Aguilera, Ahmed M. Elamir, Rana Bahij, Martijn P. W. Intven, Ganesh Radhakrishna, Issa Mohamad, Jeremy De Leon, Hendrick Tan, Shirley Lewis, Cihan Gani, Teo Stanecu, Veronica Dell’Acqua, Ali Hosni
Publikováno v:
Current Oncology, Vol 30, Iss 10, Pp 9230-9243 (2023)
The utilization of stereotactic body radiation therapy for the treatment of liver metastasis has been widely studied and has demonstrated favorable local control outcomes. However, several predictive factors play a crucial role in the efficacy of ste
Externí odkaz:
https://doaj.org/article/93b5c3256713441f8690ae561c877087
Autor:
Sarah Reddy, Suleyman Yasin Goksu, Nina N. Sanford, Radhika Kainthla, David Hsiehchen, Aravind Sanjeevaiah, Amy L. Jones, Georgios Karagkounis, Salwan Al Mutar, Chul Ahn, Muhammad S. Beg, Syed M. Kazmi
Publikováno v:
Cancer Medicine, Vol 12, Iss 13, Pp 14094-14103 (2023)
Abstract Background While the incidence of cholangiocarcinoma is rising, little is known about young‐onset disease. We compared clinical characteristics and outcomes between patients with young‐onset cholangiocarcinoma, diagnosed between the ages
Externí odkaz:
https://doaj.org/article/3445af5a367a486abfd7264b144f98aa
Autor:
Srinidhi J. Radhakrishnan, Suleyman Y. Goksu, Saikripa M. Radhakrishnan, Muhammad S. Beg, Nina N. Sanford, Syed M. Kazmi
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3460-3467 (2023)
Abstract Background Anal squamous cell carcinoma patients often present with significant symptoms, including pain, bleeding, and obstructive symptoms. This requires palliation‐directed therapy as a first‐line treatment to alleviate symptoms. The
Externí odkaz:
https://doaj.org/article/aec25e3dd7894c7694c82b2e2e51ac88
Autor:
Eric J. Hsu, Jamie Thomas, Robert D. Timmerman, Zabi Wardak, Tu D. Dan, Toral R. Patel, Nina N. Sanford, Dat T. Vo
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
IntroductionPoor outcomes in glioblastoma patients, despite advancing treatment paradigms, indicate a need to determine non-physiologic prognostic indicators of patient outcome. The impact of specific socioeconomic and demographic patient factors on
Externí odkaz:
https://doaj.org/article/771fe69082e74886858d806323b5c32c
Publikováno v:
Surgical Oncology Clinics of North America. 32:399-414
Autor:
Michael D. Chuong, Christopher J. Anker, Michael H. Buckstein, Maria A. Hawkins, Jordan Kharofa, Ann C. Raldow, Nina N. Sanford, Andrzej Wojcieszysnki, Jeffrey R. Olsen
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 115:545-552
Autor:
Elizabeth R. Zhang-Velten, MD, PhD, Salman A. Eraj, MD, David M. Hein, BS, Todd A. Aguilera, MD, PhD, Michael R. Folkert, MD, PhD, Nina N. Sanford, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 2, Pp 100580- (2021)
Purpose: Although single-institution series suggest potential benefit to dose escalation in definitive radiation therapy for esophageal cancer, randomized trials including intergroup-0123 and the recently presented A Randomized Trial of Dose Escalati
Externí odkaz:
https://doaj.org/article/b662673bb4764c5c8d03ad152eed3627